SEMA5B and lung cancer: In lung cancer, genomic profiling identified a distinctive molecular signature in asbestos-exposed patients compared to not-exposed, including copy number aberrations in the 2p16, 9q33.1 and 19p13 loci and MRPL1, INPP4A, SDK and SEMA5B somatic mutations [19, 20].